Year in Review: 2012 Saw Focus on Quality, Transparency; UDI Outline Emerged

CDRH maintained its regulatory push for transparency and consistency throughout 2012, taking a series of steps toward closer collaboration with devicemakers. Last summer’s ratification of FDA reform legislation, part of the device user fee reauthorization, jump-started a number of needed reforms and underscored that collaboration.
The GMP Letter